Cardiac Amyloidosis for Community Cardiologists: A Case-Based Approach

Registration opening soon for ASNC’s Cardiac Amyloidosis for Community Cardiologists: A Case-Based Approach, a three-part live webinar series taking place on June 9, 17, and 25, 2026.

Advance your expertise in cardiac amyloidosis with this 3-part live webinar series designed specifically for community-based healthcare providers. Each webinar delivers in-depth education on diagnosing, treating, and managing patients with known or suspected cardiac amyloidosis through a multidisciplinary approach.

Featuring concise didactic presentations and case-based discussions, each 2-hour session builds the skills needed to detect cardiac amyloidosis, implement current and evolving treatments, and ultimately deliver more effective, timely care.

Can’t attend live? All sessions will be recorded and made available OnDemand for registered participants.

Registration

Complimentary for ASNC Members
$25 for Non-members

Registration includes access to recordings of all three sessions, available after each webinar concludes.

Learning Objectives:

• Describe signs and symptoms of ATTR-CM, diagnostic work-up, and the therapeutic landscape of amyloidosis.
• Explain the importance of testing to rule out light chain amyloidosis.
• Recognize polyneuropathy in the diagnostic evaluation of patients.
• Discuss the role of genetic testing in effective patient management.
• Identify high-risk scenarios for suspected ATTR-CM.
• Define current and emerging treatments for ATTR-CM and when to prescribe them.
• Evaluate approaches to reach underserved populations.
• Develop strategies for appropriate patient management and multidisciplinary needs within a center of excellence.

Credits Per Webinar

Participants can earn up to 2 CME credits per webinar.

Agenda

June 9, 2026
(Part 1: Confirming the Diagnosis of ATTR-CM)

5:30 pm — Welcome and Logistics
Faculty: Melissa Lyle, MD, and David Wolinsky, MD, MASNC

5:35 pm — Keynote: ATTR-CM: Where We Are Today
Faculty: Mazen Hanna, MD

6:00 pm — Maximizing the Value of ECHO Interpreting and Reporting
Faculty: Craig Asher, MD

6:15 pm — MGUS vs Al Amyloid: When to Call Hematology
Faculty: Angela Dispenzieri, MD

6:30 pm — Bone Scintigraphy: The Cornerstone for Diagnosis
Faculty: Wael Jaber, MD

6:45 pm — Cardiac Comorbidities and Risk of ATTR-CM
Faculty: David Wolinsky MD

7:00 pm — Challenging Diagnostic Cases
Faculty: Melissa Lyle, MD

7:30 pm — Q&A
Faculty: Melissa Lyle, MD, David Wolinsky, MD, and Panelists

7:45 pm — Adjourn

June 17, 2026
(Part 2: State of the Art Treatment in ATTR-CM)

5:30 pm — Welcome, Logistics, Highlights from Part 1
Faculty: Melissa Lyle, MD, and David Wolinsky, MD

5:35 pm — Keynote: State of the Art of Disease Modifying Therapy 2026
Faculty: Jose Nativi Nicolau, MD

6:00 pm — Ablation, Drug Therapy, When To Give Up and Accept AFib
Faculty: Christopher McLeod, MB, ChB, PhD

6:15 pm — Treatment of the Octogenarian with ATTR-CM
Faculty: David Wolinsky, MD, MASNC

6:30pm — Identifying Disease Progression-Imaging, Biomarkers, or Clinical Assessment
Faculty: Dia Smiley, DO

6:45 pm — Cases with Fellows-in-Training
Faculty: Jose Nativi Nicolau, MD, and David Wolinsky, MD

7:15 pm — Q&A
Faculty: David Wolinsky, MD, and Panelists

7:35 pm — Adjourn

June 25, 2026
(Part 3: Advancing Care in ATTR-CM)

5:30 pm — Welcome, Logistics, Highlights from Part 2
Faculty: Melissa Lyle, MD, and David Wolinsky, MD, MASNC

5:35 pm — Keynote: How Will AI Evolve in CA by 2030
Faculty: Grace Lin, MD

6:00 pm — Closing the Gap: Identifying V122I ATTR in African American Communities
Faculty: Trejeeze Martyn, MD

6:15 pm — ATTR‑CM Meets Neuropathy: What We Know, What We Treat, What’s Coming
Faculty: Marcus Pinto, MD, MS

6:30 pm — Indications for CRT and/or LBBB pacing
Faculty: John Bibawy, MD

6:45 pm — Transplant: Who and When
Faculty: Melissa Lyle, MD

7:00 pm — Advanced Imaging PET/SPECT/MRI
Faculty: Dia Smiley, DO

7:15 pm — Clinical Trials: Potential New Therapies
Faculty: David Snipelisky, MD

7:30 pm — Centers of Excellence in the Future
Faculty: Awais Malik, MD 

7:45 pm — Q&A and Closing Remarks
Faculty: David Wolinsky, MD 

8:00 pm — Adjourn

*Credits subject to change.

Supported by unrestricted educational grant from BridgeBio.